Plain-English translation of NCT06247397 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding high-flow oxygen therapy during the night—on top of the regular oxygen therapy you already use—can help people with severe chronic lung disease breathe better and stay healthier. Researchers want to see if this extra support at night, when breathing is often hardest, makes a real difference in how you feel and how often you need to go to the hospital.
Many people with chronic lung disease struggle with low oxygen levels, especially at night, and are at high risk of serious complications. Doctors want to know if this treatment can reduce those risks and improve quality of life.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to either continue your regular oxygen therapy alone or add high-flow oxygen therapy during the night. You'll keep using your regular daytime oxygen as usual. The study lasts up to one year, and the research team will monitor how you're doing through regular check-ins using Sweden's respiratory health registry, tracking your symptoms, hospital visits, and overall health.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Sweden